-
Cao G, Meng X, Xue R, Zhu Y, Zhang X, Pan Z, Zheng X, Gong C, 2012: Characterization of the complete genome segments from BmCPV-SZ, a novel Bombyx mori cypovirus 1 isolate[J]. Can J Microbiol, 58, 872-883. doi: 10.1139/w2012-064
-
Chen S, Hou C, Bi H, Wang Y, Xu J, Li M, James AA, Huang Y, Tan A (2017) Transgenic clustered regularly interspaced short palindromic repeat/Cas9-Mediated viral gene targeting for antiviral therapy of Bombyx mori nucleopolyhedrovirus. J Virol. https: https://doi.org/10.1128/JVI.02465-16
-
Dong ZQ, Zhang J, Chen XM, He Q, Cao MY, Wang L, Li HQ, Xiao WF, Pan CX, Lu C, Pan MH, 2014: Bombyx mori nucleopolyhedrovirus ORF79 is a per os infectivity factor associated with the PIF complex[J]. Virus Res, 184, 62-70. doi: 10.1016/j.virusres.2014.02.009
-
Dong ZQ, Hu N, Zhang J, Chen TT, Cao MY, Li HQ, Lei XJ, Chen P, Lu C, Pan MH (2015) Oligomerization of baculovirus LEF-11 is involved in viral DNA replication. PLoS ONE 10: e0144930
-
Dong ZQ, Chen TT, Zhang J, Hu N, Cao MY, Dong FF, Jiang YM, Chen P, Lu C, Pan MH, 2016: Establishment of a highly efficient virus-inducible CRISPR/Cas9 system in insect cells[J]. Antiviral Res, 130, 50-57. doi: 10.1016/j.antiviral.2016.03.009
-
Dong ZQ, Hu N, Dong FF, Chen TT, Jiang YM, Chen P, Lu C, Pan MH, 2017: Baculovirus LEF-11 Hijack Host ATPase ATAD3A to promote virus multiplication in Bombyx mori cells[J]. Sci Rep, 7, 46187-. doi: 10.1038/srep46187
-
Dong Z, Dong F, Yu X, Huang L, Jiang Y, Hu Z, Chen P, Lu C, Pan M, 2018a: Excision of nucleopolyhedrovirus form transgenic silkworm using the CRISPR/Cas9 system[J]. Front Microbiol, 9, 209-. doi: 10.3389/fmicb.2018.00209
-
Dong Z, Huang L, Dong F, Hu Z, Qin Q, Long J, Cao M, Chen P, Lu C, Pan MH, 2018b: Establishment of a baculovirus-inducible CRISPR/Cas9 system for antiviral research in transgenic silkworms[J]. Appl Microbiol Biotechnol, 102, 9255-9265. doi: 10.1007/s00253-018-9295-8
-
Dong Z, Hu Z, Qin Q, Dong F, Huang L, Long J, Chen P, Lu C, Pan M, 2019: CRISPR/Cas9 mediated disruption of the ie-0 and ie-2 as a therapeutic approach to BmNPV in transgenic silkworm[J]. Insect Mol Biol., 28, 112-122. doi: 10.1111/imb.v28.1
-
Gomi S, Majima K, Maeda S, 1999: Sequence analysis of the genome of Bombyx mori nucleopolyhedrovirus[J]. J Gen Virol, 80, 1323-1337.
-
Harrison RL, Herniou EA, Jehle JA, Theilmann DA, Burand JP, Becnel JJ, Krell PJ, van Oers MM, Mowery JD, Bauchan GR, 2018: ICTV virus taxonomy profile: Baculoviridae[J]. J Gen Virol, 99, 1185-1186. doi: 10.1099/jgv.0.001107
-
Hu Y, O'Boyle K, Auer J, Raju S, You F, Wang P, Fikrig E, Sutton RE (2017) Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFkappaBeta signaling by stabilizing IkappaBalpha. PLoS Pathog 13: e1006187
doi:10.1371/journal.ppat.1006187 -
Isobe R, Kojima K, Matsuyama T, Quan GX, Kanda T, Tamura T, Sahara K, Asano SI, Bando H, 2004: Use of RNAi technology to confer enhanced resistance to BmNPV on transgenic silkworms[J]. Arch Virol, 149, 1931-1940. doi: 10.1007/s00705-004-0349-0
-
Jang DE, Lee JY, Lee JH, Koo OJ, Bae HS, Jung MH, Bae JH, Hwang WS, Chang YJ, Lee YH, Lee HW, Yeom SC, 2018: Multiple sgRNAs with overlapping sequences enhance CRISPR/Cas9-mediated knock-in efficiency[J]. Exp Mol Med, 50, 16-. doi: 10.1038/s12276-018-0037-x
-
Jiang L, Xia Q, 2014: The progress and future of enhancing antiviral capacity by transgenic technology in the silkworm Bombyx mori[J]. Insect Biochem Mol Biol, 48, 1-7. doi: 10.1016/j.ibmb.2014.02.003
-
Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD, 2018: Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors[J]. Cell, 173, 665-676. doi: 10.1016/j.cell.2018.02.033
-
Li Y, Zadori Z, Bando H, Dubuc R, Fediere G, Szelei J, Tijssen P, 2001: Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid[J]. J Gen Virol, 82, 2821-2825. doi: 10.1099/0022-1317-82-11-2821
-
Ma SY, Smagghe G, Xia QY (2018) Genome editing in Bombyx mori: new opportunities for silkworm functional genomics and the sericulture industry. Insect Sci. https: https://doi.org/10.1111/1744-7917.12609
-
Mahas A, Mahfouz M, 2018: Engineering virus resistance via CRISPR-Cas systems[J]. Curr Opin Virol, 32, 1-8. doi: 10.1016/j.coviro.2018.06.002
-
Mikhailov VS, 2003: Replication of the baculovirus genome[J]. Mol Biol, 37, 288-299.
-
Naito Y, Hino K, Bono H, Ui-Tei K, 2015: CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites[J]. Bioinformatics, 31, 1120-1123. doi: 10.1093/bioinformatics/btu743
-
Ono C, Kamagata T, Taka H, Sahara K, Asano S, Bando H, 2012: Phenotypic grouping of 141 BmNPVs lacking viral gene sequences[J]. Virus Res, 165, 197-206. doi: 10.1016/j.virusres.2012.02.016
-
Pan MH, Cai XJ, Liu M, Lv J, Tang H, Tan J, Lu C, 2010: Establishment and characterization of an ovarian cell line of the silkworm Bombyx mori[J]. Tissue Cell, 42, 42-46. doi: 10.1016/j.tice.2009.07.002
-
Pellagatti A, Dolatshad H, Valletta S, Boultwood J, 2015: Application of CRISPR/Cas9 genome editing to the study and treatment of disease[J]. Arch Toxicol, 89, 1023-1034. doi: 10.1007/s00204-015-1504-y
-
Ponnuvel KM, Nakazawa H, Furukawa S, Asaoka A, Ishibashi J, Tanaka H, Yamakawa M, 2003: A lipase isolated from the silkworm Bombyx mori shows antiviral activity against nucleopolyhedrovirus[J]. J Virol, 77, 10725-10729. doi: 10.1128/JVI.77.19.10725-10729.2003
-
Sakuma T, Masaki K, Abe-Chayama H, Mochida K, Yamamoto T, Chayama K, 2016: Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus[J]. Genes Cells, 21, 1253-1262. doi: 10.1111/gtc.2016.21.issue-11
-
Schiml S, Puchta H, 2016: Revolutionizing plant biology: multiple ways of genome engineering by CRISPR/Cas[J]. Plant Methods, 12, 8-. doi: 10.1186/s13007-016-0103-0
-
Schiwon M, Ehrke-Schulz E, Oswald A, Bergmann T, Michler T, Protzer U, Ehrhardt A, 2018: One-vector system for multiplexed CRISPR/Cas9 against hepatitis B virus cccDNA utilizing high-capacity adenoviral vectors[J]. Mol Ther Nucleic Acids, 12, 242-253. doi: 10.1016/j.omtn.2018.05.006
-
Tsukamoto T, Sakai E, Iizuka S, Taracena-Gandara M, Sakurai F, Mizuguchi H, 2018: Generation of the adenovirus vector-mediated CRISPR/Cpf1 system and the application for primary human hepatocytes prepared from humanized mice with chimeric liver[J]. Biol Pharm Bull, 41, 1089-1095. doi: 10.1248/bpb.b18-00222
-
Vanarsdall AL, Mikhailov VS, Rohrmann GF, 2007: Baculovirus DNA replication and processing[J]. Curr Drug Targets, 8, 1096-1102. doi: 10.2174/138945007782151397
-
Yao H, He F, Guo A, Cao C, Lu X, Wu X, 2008: Gene analysis of an antiviral protein SP-2 from Chinese wild silkworm, Bombyx mandarina Moore and its bioactivity assay[J]. Sci China C Life Sci, 51, 879-884. doi: 10.1007/s11427-008-0123-8
-
Yin LJ, Hu SQ, Guo F, 2015: The application of CRISPR-Cas9 gene editing technology in viral infection diseases[J]. Hereditas, 37, 412-418.
-
Yin L, Hu S, Mei S, Sun H, Xu F, Li J, Zhu W, Liu X, Zhao F, Zhang D, Cen S, Liang C, Guo F, 2018: CRISPR/Cas9 inhibits multiple steps of HIV-1 infection[J]. Hum Gene Ther, 29, 1264-1276. doi: 10.1089/hum.2018.018
-
Zhang J, He Q, Zhang CD, Chen XY, Chen XM, Dong ZQ, Li N, Kuang XX, Cao MY, Lu C, Pan MH, 2014a: Inhibition of BmNPV replication in silkworm cells using inducible and regulated artificial microRNA precursors targeting the essential viral gene lef-11[J]. Antivir Res, 104, 143-152. doi: 10.1016/j.antiviral.2014.01.017
-
Zhang P, Wang J, Lu Y, Hu Y, Xue R, Cao G, Gong C, 2014b: Resistance of transgenic silkworm to BmNPV could be improved by silencing ie-1 and lef-1 genes[J]. Gene Ther, 21, 81-88. doi: 10.1038/gt.2013.60
-
Zhang J, Graham S, Tello A, Liu H, White MF, 2016: Multiple nucleic acid cleavage modes in divergent type III CRISPR systems[J]. Nucleic Acids Res, 44, 1789-1799. doi: 10.1093/nar/gkw020
-
Zhou F, Chen RT, Lu Y, Liang S, Wang MX, Miao YG, 2014: piggyBac transposon-derived targeting shRNA interference against the Bombyx mori nucleopolyhedrovirus (BmNPV)[J]. Mol Biol Rep, 41, 8247-8254. doi: 10.1007/s11033-014-3726-0